Vicarious Surgical (RBOT) Notes Payables (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Notes Payables came in at $525000.0 in Q4 2025, up 323.39% on a QoQ basis from $124000.0 in Q2 2020.
Vicarious Surgical (RBOT) Notes Payables (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 2 years of Notes Payables data on file, last reported at $525000.0 in Q4 2025.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $525000.0 in Q4 2025; TTM through Dec 2025 was $525000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $525000.0, changed N/A from the prior year.
- Notes Payables for Q4 2025 stood at $525000.0, up from $124000.0 in the prior quarter.
- Over the last five years, Notes Payables for RBOT reached as high as $525000.0 in Q4 2025 and fell as low as $525000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 525,000.00 |
| Jun 30, 2020 | 124,000.00 |